Related by context. All words. (Click for frequent words.) 74 DermaVir 73 Thiovir 72 nucleoside analog 71 TRO# 71 oral prodrug 71 Multimeric 71 IMA# 71 nucleotide analog 71 Traficet EN 70 liposomal formulation 70 alvespimycin 70 Sapacitabine 70 CCR5 antagonist 70 multicenter Phase II 70 Initiate Clinical Trial 70 Phase 1a clinical 70 elotuzumab 70 OMP #M# 70 Aganocide 70 mertansine 70 Phase Ib study 69 MAGE A3 ASCI 69 GRNVAC1 69 HuMax EGFr 69 Sym# 69 Archexin 69 TLR9 agonist 69 Elvitegravir 69 OvaRex R 69 AAG geldanamycin analog 69 Tesetaxel 69 targeted radiotherapeutic 69 Phase Ib clinical 69 EndoTAG 69 RhuDex ® 69 Therapeutic Vaccine 69 pharmacokinetic PK study 69 TransVax tm 69 PNP inhibitor 69 Safinamide 69 non nucleoside inhibitor 69 KRN# 69 maturation inhibitor 69 YONDELIS 69 ganetespib 69 Symadex 69 relapsed MM 68 forodesine 68 IRX 2 68 JVRS 68 JAK2 inhibitor 68 CRLX# 68 FOLOTYN ® 68 CEQ# 68 Azedra 68 orally bioavailable 68 HGS# 68 phase Ib 68 therapeutic monoclonal antibody 68 TransVax TM 68 Panzem R NCD 68 REMUNE R 68 immunotherapeutic vaccine 68 MVA BN R 68 PDE4 inhibitor 68 TG# [003] 68 novel VDA molecule 68 preclinically 68 Omacetaxine 68 OHR/AVR# 68 R#/MEM # 68 SNT MC# 68 HQK 68 investigational integrase inhibitor 68 velafermin 68 farletuzumab 68 Immunotherapeutic 68 CYT# potent vascular disrupting 68 Tarvacin TM 68 Personalized Immunotherapy 68 AdVac ® 68 indibulin 68 Phase #b/#a clinical 68 targeting CD# 68 Aflibercept 68 Maribavir 68 MGd 68 intranasal formulation 68 Blinatumomab 68 Oral NKTR 68 Universal Flu Vaccine 68 Pafuramidine 68 receptor tyrosine kinase inhibitor 68 Onconase 68 Bezielle 68 riociguat 68 ImmunoVEX 68 Phase #/#a 68 PSMA ADC 68 NP2 Enkephalin 68 Glufosfamide 67 First Patient Dosed 67 TMC# [002] 67 orally inhaled migraine 67 Vacc 4x 67 R roscovitine 67 Vaxfectin ® 67 Altastaph 67 Alocrest 67 Sphingomab TM 67 Cloretazine 67 Dapagliflozin 67 MT# MEDI 67 TPI ASM8 67 busulfan 67 Alfacell proprietary ribonuclease 67 Allovectin 7 67 rilonacept 67 Phase Ib II 67 Cethromycin 67 BiTE 67 orally administered inhibitor 67 CCR5 mAb 67 Cardiotoxicity 67 EOquin TM 67 Civacir 67 solithromycin 67 CR# vcMMAE 67 phase IIb trial 67 PEG Interferon lambda 67 Nanobody 67 ONCONASE R 67 QLT# 67 vidofludimus 67 PRTX 67 PANVAC VF 67 Hsp# Inhibitor 67 neratinib 67 Anavex #-# 67 selective orally bioavailable 67 Vaxfectin 67 RhuDex TM 67 OncoVEX 67 budesonide foam 67 GV# [001] 67 oral antiviral 67 Virulizin ® 67 ChronVac C R 67 VitiGam 67 immunomodulator 67 CLORETAZINE TM VNP#M 67 Epratuzumab 67 HCV NS5B polymerase 67 GAMMAGARD 67 THR beta agonist 67 HuMax CD4 67 INCB# [001] 67 Pimavanserin 66 tolerability pharmacokinetics 66 Multiple Ascending Dose 66 TransVax ™ 66 ChronVac C ® 66 polymerase inhibitor 66 orally dosed 66 lipid nanoparticle 66 JAK inhibitor 66 Initiate Phase 66 registrational trial 66 PEG IFN 66 vinca alkaloid 66 Aviptadil 66 nanoviricides 66 EndoTAG TM -1 66 NEUGENE 66 IMiDs ® 66 LEAPS TM 66 TLK# 66 Xanafide 66 DAVANAT 66 cathepsin K inhibitor 66 Prodarsan R 66 CCR5 receptor antagonist 66 Anticalin R 66 phase IIb clinical 66 Alferon N 66 MT#/MEDI-# 66 SinuNase ™ 66 ascending dose 66 Phase 1b clinical 66 cannabinor 66 CA9 SCAN 66 PEG SN# 66 ALN TTR# 66 targeted antifolate 66 otelixizumab 66 PORxin TM 66 GVAX ® 66 thalidomide Thalomid 66 IMC #B 66 HCV protease inhibitors 66 Factor VIIa 66 Phase 2b Clinical Trial 66 CANCIDAS 66 non nucleoside HCV 66 PrevOnco 66 HCV SPRINT 66 BiTE R 66 Pharmacokinetics PK 66 OncoVEX GM CSF 66 phase IIa 66 Sphingomab 66 preclinical efficacy 66 DCVax R 66 rxRNA 66 metaglidasen 66 intranasal delivery 66 stated Michelle Berrey 66 agonistic human 66 blinded randomized placebo controlled 66 Ozarelix 66 radiation sensitizer 66 NRTI resistance 66 Panzem R 66 LAB CGRP 66 PEGylated interferon 66 lintuzumab 66 tigecycline 66 AEG# 66 siRNA therapeutic 66 Exelixis compounds 66 SNT-MC#/idebenone 66 NOX E# 66 romidepsin 66 Annamycin 66 evaluating tivozanib 66 pomalidomide 66 hemagglutination inhibition HAI 66 Viread tenofovir disoproxil fumarate 66 radezolid 66 CERVARIX 66 Phase 2a trial 66 eniluracil 66 replicon 66 Voreloxin 66 ritonavir boosted 66 tanespimycin 66 ELACYT 66 Daclizumab 66 SynCon ™ DNA 66 Phase #b/#a trial 66 dexpramipexole 66 CG# [003] 66 Prodarsan ® 66 Aurora kinase inhibitor 66 immatics 66 2 methoxyestradiol 66 PI3K/Akt pathway inhibitor 66 MyVax R 66 elacytarabine 66 HDAC Inhibitor 66 delafloxacin 66 Seliciclib 66 SPRYCEL ® 66 plasmid DNA pDNA 66 dasatinib Sprycel ® 66 LymphoStat B TM 66 galiximab 66 sorafenib Nexavar 66 HuMax TAC 66 investigational pan BCR 66 inhibitor RG# 66 Telatinib 66 Azacitidine 66 Initiates Phase II 66 MEK inhibitors 66 Angiocept 66 dose intramuscular 66 CTAP# Capsules 66 Carfilzomib 66 myelofibrosis polycythemia vera 66 LEVADEX ™ 66 oncolytic vaccine 66 oral talactoferrin 66 Liposomal 66 VRX# [002] 66 immunotherapeutic agent 66 phase IIa clinical 66 Spiegelmer ® 65 Tyrima 65 obatoclax 65 Tarceva TM 65 CCX# 65 IAP inhibitors 65 Phase Ib 65 Metastatic Melanoma 65 rALLy clinical trial 65 synthetic siRNA 65 VIR# 65 SAR# [004] 65 trastuzumab emtansine T DM1 65 Excellarate 65 Aurora Kinase 65 torezolid 65 HuMax HepC 65 ara C 65 LymphoStat B belimumab 65 acyclovir Lauriad R 65 systemic RNAi therapeutic 65 HGS ETR2 65 histone deacetylase HDAC inhibitor 65 Phase 1b trial 65 Kahalalide F 65 torezolid phosphate 65 Natalizumab 65 Telbivudine 65 HGS ETR1 65 ENMD # 65 PKC# 65 generation purine nucleoside 65 thymalfasin 65 humanized monoclonal 65 lentiviral vector 65 Kinoid 65 DOS# 65 Solazed 65 OvaRex ® MAb 65 humanized anti 65 Pertuzumab 65 PRT# 65 trastuzumab DM1 T DM1 65 Quinamed 65 nucleotide analogue 65 Vicriviroc 65 TBC# 65 nucleoside reverse transcriptase inhibitor 65 Mipomersen 65 Phase III Clinical Trial 65 Guanilib 65 IMP# 65 Meets Primary Endpoint 65 Diamyd R 65 demonstrated antitumor activity 65 FluCide 65 Micromet BiTE 65 HCD# [002] 65 non nucleoside 65 HuLuc# 65 pharmacodynamic properties 65 tolevamer 65 CYC# 65 Tezampanel 65 pertuzumab 65 p# inhibitor 65 ATL/TV# 65 Talabostat 65 Phase Ib clinical trials 65 investigational protease inhibitor 65 SynCon TM DNA 65 prostone 65 protease inhibitor PI 65 Elagolix 65 SinuNase TM 65 Initiates Clinical 65 SCIB1 65 Initiated Phase 65 CCR5 inhibitor 65 BrachySil TM 65 Antiangiogenic 65 oral rivaroxaban 65 zidovudine AZT 65 viral kinetics 65 Trofex 65 LHRH antagonists 65 pharmacodynamic PD 65 EGS# 65 DDP# 65 LB# [003] 65 PDX pralatrexate 65 Aliskiren 65 μg dose 65 proteasome inhibitor 65 Deforolimus 65 Nitazoxanide 65 Melphalan 65 Vaxfectin R adjuvant 65 Degarelix 65 MORAb 65 HCV protease inhibitor 65 novel oral anticoagulant 65 Decitabine 65 GLYX 65 Phase IIa trials 65 Phase 2b Trial 65 small molecule thrombopoietin 65 personalized immunotherapy 65 Phase #b/#a 65 ancrod 65 HuMax CD#b 65 Allovectin 7 ® 65 deforolimus 65 Diamyd ® 65 biologic DMARD 65 Phase IIb clinical trials 65 AKT inhibitor 65 maximally tolerated dose 65 huC# DM4 65 Alinia 65 G#DT 65 afamelanotide 65 Squalamine 65 Thiarabine 65 investigational humanized monoclonal antibody 65 MVA MUC1 IL2 65 Phase IIb Trial 65 fosbretabulin 65 Aplidin 65 Triapine R 65 HCV replicon 65 Phase 2a clinical trials 65 intravenous recombinant 65 huN# DM1 65 Actimmune ® 65 DiLA2 65 RezularTM 65 Vaccine Adjuvant 65 Akt inhibitor 65 dirucotide MBP# 65 Pegylated Interferon 65 BHT DNA 65 including eniluracil ADH 65 Anticalins R 65 GRASPA ® 65 multicenter randomized placebo controlled 65 Enhanze Technology 65 Pralatrexate 65 VivaGel TM 65 cilengitide 65 GW# [003] 65 Phase IIIb clinical 65 Vidaza azacitidine 65 NS#/#A protease 65 recombinant interferon 65 NS5B polymerase 65 pan HDAC inhibitor 65 KNS # 65 PEGylated Fab fragment 65 antibody MAb 65 SynCon 65 Immunogenicity 65 Interferon Beta 65 candidate deforolimus 65 Protease Inhibitor 65 pharmacokinetics PK 65 BioNumerik 65 Cardio Vascu Grow 65 CIMZIA TM 65 DermaPrep 65 TAFA# 65 ALN TTR 65 toenail onychomycosis 65 Aptivus ® 65 volociximab 64 Cloretazine ® 64 ceftazidime 64 PNT# 64 investigational monoclonal antibody 64 trodusquemine 64 AZT zidovudine Retrovir 64 JZP 64 OncoGel 64 TLR agonists 64 VNP#M 64 Romidepsin 64 BAY #-# 64 OncoVex 64 Lixivaptan 64 Ecallantide 64 XL# XL# 64 Laquinimod 64 telaprevir VX 64 recombinant adeno associated 64 Omacetaxine mepesuccinate 64 controlled multicenter Phase 64 Bavituximab 64 oral renin inhibitor 64 depsipeptide 64 Achieves Primary Endpoint 64 Velcade bortezomib 64 Hepatitis C Virus HCV 64 miconazole Lauriad ® 64 diarrhea predominant irritable 64 Bosutinib 64 glatiramer acetate 64 multitargeted 64 tetravalent vaccine 64 PXD# 64 recombinant subunit vaccine 64 phase IIb 64 HIV integrase inhibitors 64 ZACTIMA 64 Phase IIA 64 lead Aganocide compound 64 Pemetrexed 64 oral salmon calcitonin 64 Myocet 64 plasma kallikrein inhibitor 64 Prednisporin 64 Hyphanox 64 Dose Escalation 64 Tasimelteon 64 YONDELIS R 64 thetreatment 64 RGB # 64 CXA 64 bortezomib Velcade 64 Phase IIb III 64 Darinaparsin 64 sufentanil 64 LUX Lung 64 Naive Patients 64 trivalent influenza vaccine 64 cMET 64 Copegus ribavirin 64 VitiGam TM 64 treatment naive genotype 64 relapsed multiple myeloma 64 bendamustine 64 virus HCV protease inhibitor 64 Zolinza 64 genotypic resistance 64 ALGRX 64 TBC M4 64 ATL# [001] 64 HTS assay 64 mGluR5 NAM 64 Fodosine 64 synthetic retinoid 64 PDE# inhibitors 64 pharmacodynamic effects 64 iobenguane 64 oral methylnaltrexone 64 virosome 64 Bevirimat 64 UPLYSO 64 Randomized Phase 64 Pagoclone 64 CBLC# 64 REG2 64 TKB# 64 Microplasmin 64 Phase III Pivotal 64 OXi# 64 favorable pharmacokinetic profile 64 docetaxel Taxotere ® 64 theranostic 64 Pivotal Phase 64 EndoTAGTM 1 64 Golimumab 64 Kamada AAT 64 pharmacodynamic profile 64 Rigel R# 64 ARIKACE ™ 64 Actilon 64 prophylactic vaccine 64 Peginterferon 64 Apoptone 64 XYNTHA 64 Kinase Inhibitor 64 SAR# [002] 64 SPL# Gel vaginal microbicide 64 BAL# [002] 64 TACI Ig 64 Dasatinib 64 MEK inhibitor 64 HIV coinfected 64 posaconazole 64 MGCD# [001] 64 midstage clinical 64 nucleoside polymerase inhibitor 64 Diamyd r 64 nanoviricide drug 64 trabectedin 64 IMC A# 64 Apaziquone 64 Saquinavir 64 humanized antibody 64 NS5b 64 sorafenib tablets 64 Phase IIb trials 64 PHX# 64 ESBA# 64 antisense drug 64 Infected Patients 64 Janus kinase 64 Telintra 64 potent cytotoxic 64 immunotherapeutics 64 nalbuphine ER 64 oral ridaforolimus 64 ongoing Phase 1b 64 subcutaneous formulation 64 MVA BN 64 PSN# [002] 64 CMV vaccine 64 GSK# [001] 64 EZN 64 Raltegravir 64 pharmacodynamic markers 64 Cloretazine VNP#M 64 constipation OIC 64 dopamine partial agonist 64 rPA anthrax vaccine 64 LEUKINE 64 resminostat 64 SUTENT ® 64 Temsirolimus 64 CA4P 64 Antitumor Activity 64 ISF# 64 DepoVax TM 64 Vaxfectin R 64 Completes Patient Enrollment 64 Acute Ischemic Stroke 64 dasatinib Sprycel 64 GeoVax vaccine 64 XOMA 3AB 64 Initiates Enrollment 64 integrase inhibitor 64 GMX# 64 dose escalation Phase 64 Recombinant Human 64 hyaluronidase enzyme 64 Atripla combines 64 NXL# 64 generation NNRTI 64 AEGR 64 topical gel containing 64 valent pneumococcal conjugate vaccine 64 Zybrestat 64 Dalbavancin 64 vapreotide acetate 64 randomized controlled Phase 64 NPC 1C 64 lintuzumab SGN 64 boosted protease inhibitor 64 DU #b 64 MVA#A 64 Ampligen ® 64 Amplimexon 64 Chemophase 64 refractory CLL 64 Fludara ® 64 EDEMA3 trial 64 Technosphere ® 64 ATL# [002] 64 VITAL Trial 64 Fc fusion protein 64 Phase III Clinical Trials 64 MVA BN ® 64 bortezomib Velcade R 64 orally inhaled 64 PrevOnco ™ 64 Cloretazine R VNP#M 64 Elesclomol 64 EOquin 64 OvaRex MAb 64 dose pharmacokinetic 64 GSK '# 64 lorvotuzumab mertansine 64 Hedgehog Pathway Inhibitor 64 immune modulatory 64 Phase IIa trial 64 samalizumab 64 interferon gamma 1b 64 vinorelbine tartrate 64 corticosteroid dexamethasone 64 Inhalation Solution 64 Cannabinor 64 BGC# 64 Anticalins 64 teriflunomide 63 highly immunogenic 63 BZL# 63 dose escalation clinical 63 effector function 63 refractory chronic lymphocytic 63 Veronate 63 Anticalins ® 63 PEGylated anti 63 Nanobody ® 63 XmAb# 63 pafuramidine maleate 63 Anticalin ® 63 Panzem NCD 63 VersaFilm 63 DexaSite 63 DEB# 63 Demonstrates Potent 63 Xcellerated T Cells 63 davunetide intranasal AL 63 antiviral efficacy 63 SynCon TM 63 Interferon Alpha 63 pharmacokinetic pharmacodynamic 63 p# biomarker 63 ImmuKnow R 63 Cytolin ® 63 AZILECT R 63 Muraglitazar 63 nasal powder 63 Interferon alfa 63 entinostat 63 pharmacokinetic equivalence 63 reslizumab 63 Dendritic Cell 63 BrachySil 63 MKC# MT 63 AFFiRiS 63 denileukin diftitox 63 Pazopanib 63 Adjuvanted 63 Chemokine Receptor 63 Successfully Completes Phase 63 CCX# B 63 StemEx 63 PENNVAX B 63 TMC# C# 63 Plicera 63 Afatinib 63 anticancer compound 63 IAP inhibitor 63 CDK inhibitor 63 Curaxin 63 chemokine receptor 63 pharmacokinetic interactions 63 INSPIRE Trial Phase III 63 ocular formulation 63 AV HALT 63 trastuzumab Herceptin R 63 systemically administered 63 interferon beta therapy 63 ascending doses 63 Phase 2a Trial 63 Clinical Trial Results 63 StemEx R 63 neuraminidase inhibitor 63 MVA nef 63 NeuroVax 63 PD LID 63 phase IIb III 63 #D#C# 63 histamine dihydrochloride 63 Bicifadine 63 treatment naïve genotype 63 HuMax CD# 63 Zemplar Capsules 63 CIMZIA TM certolizumab pegol 63 AZILECT ® 63 ZD# [001] 63 adenoviral vectors 63 pegylated interferon alfa 2a 63 r hGH 63 Darunavir 63 Silodosin 63 novel peptide 63 bevacizumab Avastin ® 63 pyrazinamide 63 XmAb 63 Interferon alpha 63 Ridaforolimus 63 BiovaxID TM 63 MAXY alpha 63 Intravenous CP 63 multicenter Phase III 63 RNAi Therapeutic 63 Zalypsis 63 SYN# 63 PROSTVAC TM 63 Aurora kinase 63 H#N# VLP vaccine 63 abacavir Ziagen 63 RhuDex 63 ponatinib 63 MyVax ® 63 HCV Genotype 63 Lodotra TM 63 immunotherapeutic 63 Fx #A 63 Antiviral Activity 63 Zenvia ™ 63 FOLFOX6 63 DepoVax 63 seliciclib CYC# 63 Valopicitabine 63 Adenoviral 63 protein tyrosine phosphatase 1B 63 ORENCIA ® 63 acetonide FA 63 gastrin analogue TT 63 phase IIb study 63 MAP# 63 BARACLUDE R 63 chimeric monoclonal antibody 63 tenofovir TDF 63 aplindore 63 XYZAL R 63 Tarvacin 63 USL# 63 IMPDH inhibitor 63 Vaccine Candidate 63 orBec 63 pafuramidine 63 vascular disrupting agents 63 Cerashield 63 topically administered 63 HIV integrase inhibitor 63 immunotoxin 63 MNTX 63 Ophena TM 63 VAX# 63 Albuferon TM 63 ularitide 63 CCR5 tropic HIV 63 eTag assays 63 nucleotide analogs 63 conserved antigens NP 63 enzastaurin 63 SPRIX ® 63 antitumor effect 63 elvucitabine 63 p# antigen 63 hepatitis C HCV 63 Enzastaurin 63 therapeutic monoclonal antibodies 63 forodesine hydrochloride 63 Panzem ® 63 kinase inhibition 63 lumiliximab 63 Interferon beta 63 MEK Inhibitor 63 Etravirine 63 antiangiogenesis 63 AZT 3TC 63 Irinotecan 63 Alzhemed TM 63 HEPLISAV ™ 63 ELND-#/AZD-# 63 dacetuzumab 63 Monoclonal 63 omacetaxine mepesuccinate 63 Elotuzumab 63 unique alkylating agent 63 SCH # 63 GelSite R polymer 63 Pivotal Phase III 63 MAb 63 Bioral ® 63 Presents Preclinical Data 63 Onalta 63 xenograft models 63 siRNAs targeting 63 Prospective Randomized 63 Drug Candidate 63 CRMD# 63 tipranavir 63 Monoclonal antibody 63 vosaroxin 63 Nanobody R 63 Cytotoxicity 63 Phase IIb Clinical Trial 63 RhuDex R 63 tgAAC# 63 Protein Interactions 63 CoFactor 63 ISTODAX 63 Vaxfectin R formulated 63 isoform selective 63 lenalidomide Revlimid R 63 mapatumumab 63 Phase 1b clinical trials 63 anticoagulant reversing agent 63 Solazed TM 63 Phase 2a Clinical Trial 63 RE LY ® 63 Lu AA# 63 BEZ# 63 TASKi2 63 Dual Opioid 63 sapacitabine CYC# 63 CIMZIA ™ 63 rifabutin 63 dose dose escalation 63 BEXXAR Therapeutic Regimen 63 ASONEP 63 edifoligide 63 Hepatotoxicity 63 RNAi therapeutic targeting 63 Inhaled AAT 63 novel immunotherapeutic 63 Maximum Tolerated Dose MTD 63 ToGA 63 humanised monoclonal antibody 63 Vandetanib 63 Antigenics QS 63 retaspimycin 63 Presents Preclinical 63 multi kinase inhibitor 63 hypereosinophilic syndrome 63 Allovectin 7 R 63 apricitabine ATC 63 NTDDS 63 vascular disrupting agent 63 VEGFR2 inhibitor 63 subcutaneous SC 63 placebo controlled Phase 63 telomerase therapeutic 63 Arcelis ™ 63 Ceftaroline 63 angiogenesis inhibitor 63 ORMD 63 JAK1 63 PI3K inhibitor 63 Entry Inhibitor 63 BNC# 63 oral FTY# 63 PEGylated 63 exon skipping 63 somatostatin analog 63 oral beclomethasone dipropionate 63 Sustiva efavirenz 63 Combination REOLYSIN R 63 Bendamustine 63 evaluating satraplatin 63 NEUGENE antisense 63 CYP#A# CYP#D# 63 etanercept Enbrel 63 apricitabine 63 sodium thiosulfate STS 63 epigenetic therapies 63 IMiDs ® compound 63 Janus Kinase 63 dosing cohort 63 Tesmilifene 63 recurrent glioblastoma multiforme 63 AdVac 63 oral taxane 63 selective modulator 63 HGS ETR1 mapatumumab 63 GSK# [002] 63 zanolimumab 63 JNJ Q2 63 Locked Nucleic Acid LNA 63 delipidation 63 Dacogen injection 63 Clevudine 63 5 HT3 antagonist 63 Onalta ™ 63 recombinant polyclonal antibody 63 VivaGel ™ 63 TRX1 63 Solulin 63 STRIDE PD 63 Antibody Drug Conjugate 63 Azedra TM 63 inhaled liposomal ciprofloxacin 63 sulodexide 63 Neulasta ® 63 Mg Uk 63 refractory gout 63 Ag Ab Combo 63 alfa 2a 63 S/GSK# 63 dose escalation trial 63 EndoTAG TM 63 acyclovir Lauriad ® 63 Phase IIa clinical 63 Onrigin 63 Oritavancin 62 Aryplase 62 delivers fluocinolone acetonide FA 62 Phase Ib IIa 62 Cytolin 62 Pyridorin 62 small molecule Hedgehog 62 ELND# 62 HEPLISAV Phase 62 Factor Xa inhibitor 62 Monoclonal Antibody 62 peptide antigens 62 Mycophenolate Mofetil 62 Cleviprex TM clevidipine 62 dosage regimens 62 radiolabeled TM# 62 sodium glucose cotransporter 62 neuronal nicotinic receptor NNR 62 Arimoclomol 62 TOCOSOL 62 intradermal injection 62 Granulocyte Colony Stimulating Factor